KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.89 $4.97 Friday, 26th Apr 2024 ALDX stock ended at $3.93. This is 0.254% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.79% from a day low at $3.83 to a day high of $3.98.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
Oct 26, 2023 $1.56 $1.59 $1.51 $1.57 674 348
Oct 25, 2023 $1.57 $1.61 $1.49 $1.55 733 471
Oct 24, 2023 $1.47 $1.67 $1.46 $1.59 1 073 437
Oct 23, 2023 $1.62 $1.65 $1.47 $1.49 1 364 549
Oct 20, 2023 $1.65 $1.75 $1.58 $1.65 1 752 675
Oct 19, 2023 $1.67 $1.75 $1.62 $1.66 1 559 898
Oct 18, 2023 $1.80 $1.98 $1.67 $1.73 4 970 650
Oct 17, 2023 $1.80 $1.96 $1.75 $1.84 4 909 737
Oct 16, 2023 $1.42 $2.55 $1.42 $1.83 21 402 942
Oct 13, 2023 $5.42 $5.47 $5.22 $5.43 478 577
Oct 12, 2023 $5.55 $5.57 $5.32 $5.39 491 653
Oct 11, 2023 $5.95 $5.99 $5.49 $5.53 400 708
Oct 10, 2023 $5.79 $6.01 $5.76 $5.94 416 728
Oct 09, 2023 $5.81 $5.85 $5.63 $5.77 301 514
Oct 06, 2023 $5.69 $5.90 $5.68 $5.88 442 380
Oct 05, 2023 $5.65 $5.93 $5.56 $5.82 651 424
Oct 04, 2023 $5.84 $5.84 $5.53 $5.61 797 948
Oct 03, 2023 $6.04 $6.05 $5.77 $5.86 557 025
Oct 02, 2023 $6.70 $6.74 $6.00 $6.06 1 104 585
Sep 29, 2023 $6.32 $6.74 $6.27 $6.68 2 135 339
Sep 28, 2023 $6.12 $6.30 $6.03 $6.26 507 284
Sep 27, 2023 $6.20 $6.30 $6.03 $6.11 457 488
Sep 26, 2023 $6.15 $6.55 $6.13 $6.15 440 061
Sep 25, 2023 $6.10 $6.22 $5.95 $6.15 575 581
Sep 22, 2023 $6.19 $6.37 $6.12 $6.14 427 417
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT